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Abstract Rab proteins are small GTPases involved in the regu- 
lation of membrane traffic. Rab5a has been shown to regulate 
transport in the early endocytic pathway. Here we report the 
isolation of cDNA clones encoding two highly related isoforms, 
Rab5b and Rab5c. The two proteins share with Rab5a all the 
structural features required for regulation of endocytosis. Rab5b 
and Rab5c colocalize with the both transferrin receptor and 
Rab5a, stimulate the homotypic fusion between early endosomes 
in vitro and increase the rate of endocytosis when overexpressed 
in vivo. These data demonstrate that three Rab5 isoforms co- 
operate in the regulation of endocytosis in eukaryotic cells. 
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1. Introduction 
A common feature of the Ras superfamily of small GTPases 
is the existence of subgroups of structurally related isoforms 
sharing high sequence identity (80-90%) [1]. Isoforms are 
widely found among members of the different subfamilies. For 
example, three highly related Ras proteins, H-Ras, K-Ras and 
N-Ras, constitute a subgroup in the Ras subfamily. Other 
isoforms are RaplA and RaplB, Rap2A and Rap2B, and 
Ra lA  and RalB. Examples of isoforms in the Rho subfamily 
are RholA and RholC, and Racl and Rac2. The ARF subfam- 
ily also contains everal highly related proteins [2,3] and, re- 
cently, two isoforms of Sarl (SarlA and SarlB) have been 
identified in mammalian cells [4]. 
Subgroups of highly homologous proteins exist also in the 
Rab protein subfamily. In the case of Rabl two isoforms, 
Rabla and Rablb, have been discovered [5]. These two pro- 
teins have been shown to colocalize at the level of the interme- 
diate compartment and seem to have a similar role in control- 
ling ER to Golgi transport. However, proteins that share high 
sequence homology do not necessarily share the same func- 
tional role. For example, the Rab3 subgroup accounts for at 
least four isoforms (Rab3a, Rab3b, Rab3c and Rab3d) sharing 
high sequence identity (77-85%). However, while Rab3a ap- 
pears to be only expressed in neurons and neuroendocrine c lls 
and, together with Rab3c, regulates neurotransmitter release 
[7-11], Rab3b seems to be specifically expressed in polarized 
epithelial cells [12] and appears to have a divergent function 
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[13]. The Rab3d protein is mainly expressed in adipocytes and 
might be involved in glucose transporter t afficking in response 
to insulin stimulation [14]. Finally, a possible fifth member of 
this subgroup has been discovered in the cytoplasmic site of 
zymogen granules of pancreatic acinar cells [6]. Therefore, this 
subgroup of closely related proteins eems to be quite heteroge- 
neous, its members having a cell type specific localization and 
possibly different functions. For Rab4 two isoforms have been 
discovered: Rab4a is present on the early endosome and regu- 
late recycling but the localization and the function of Rab4b are 
not yet known [15-17]. 
Rab5 is a protein localized to the plasma membrane, clathrin 
coated vesicles and early endosomes and is ubiquitously ex- 
pressed [18,19]. The protein is essential for in vitro homotypic 
fusion of early endosomes and is able to increase the rate of 
endocytosis n vivo when overexpressed [19,20]. It has recently 
being renamed Rab5a since the discovery of two partial cDNA 
clones highly related that were then called Rab5b and Rab5c 
[21,22]. This indicated the presence of a subgroup of at least 
three Rab5 protein in mammalian cells. Interestingly in yeast, 
three highly related Rab5 proteins have been isolated and 
named Ypt51p, Ypt52p, Ypt53p [23]. These proteins hare be- 
tween 52% and 54% identity with canine Rab5a and seem to 
have similar or at least overlapping functions in the endocytic 
pathway, suggesting a similarity with the situation in mammal- 
ian cells. Do mammalian Rab5a, Rab5b and Rab5c perform 
different functions, similar to the members of the Rab3 sub- 
group, or do they share the same role? Given that neither the 
intracellular localization, nor the tissue distribution or the 
function of the Rab5b and Rab5c isoforms has been investi- 
gated yet, we decided to begin the functional characterization 
of these proteins. In this study we report the isolation of full- 
length cDNA clones for Rab5b and Rab5c. Furthermore, we 
investigated the localization and fucntion of these proteins in 
BHK cells using a combination of in vitro and in vivo assays. 
Our results indicate that three Rab5 proteins regulate the dy- 
namics of early endosomes fusion and the rate of endocytosis 
in eukaryotic ells. 
2. Materials and methods 
2.1. Cloning of mouse Rab5b 
Based on the partial sequence previously identified [21], a 5' RACE 
protocol was performed essentially as described [21]. The universal 
primers KXEB and KXEBpoly(C) were used in combination with the 
nested gene-specific primers R1 (5'-TCGAGGATCCATCTAAACA- 
CCGGA-Y) and R2 (5'-ACCTCGAGGATCCGGATTGGGTGAG- 
GAAGC-Y). For both PCRs, an annealing temperature of 60°C was 
used. The amplification products of the second PCR were subcloned 
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into pGEM1 (Promega Corp.) and analyzed by double-stranded DNA 
sequencing using the T7 Sequencing kit (Pharmacia Fine Chemicals). 
Since the sequence of the clones containing the 5' end of murine 
Rab5b were found to be identical to the one of human Rab5b [22], the 
sequence could be extended to the 3' end of the coding region by two 
sequential PCRs using sets of nested primers derived from the 5' of the 
open reading frame obtained by RACE (SI: 5'-CTCCTACTTTGAT- 
AACCTG-3'; $2: 5'-CCGAGAATTCATATGACTAGCAGAAGTA- 
CAGCC-3') and from the 3'-untranslated region of the human Rab5b 
(R3: 5'-CTTAGCTCTTGTGCTAGCTCC-3'; R4: 5'-ACGTGGATC- 
CTTGTTTGCTGCTAGCCACC-3'; [22]. The first PCR was carried 
out under standard conditions (20 ml volume, 50 mM KCI, 10 mM 
Tris-HC1, pH 8.3, 1.5 mM MgCI2, 0.01% gelatin, 200 ¢tM of dATE 
dGTP, dCTP, dTTE 20 pmol of S1 and R3 and one unit of Amplitaq 
(Perkin Elmer Cetus) using 0.4 ffl of first strand cDNA [21] as template. 
The reaction was overlaid with 20/~1 of mineral oil (Sigma Immuno- 
chemicals), transferred to a programmable thermal cycler (Perkin 
Elmer Cetus) and incubated for 30 cycles of 94°C for 1 min, 55°C for 
2 rain, and 72°C for 1 min with a final extension at 72°C for 2 min. The 
PCR products were run on a 1% Seaplaque agarose (FMC Corp. 
Bioproducts) gel and excised. The agarose was melted and 5/11 were 
used as the template for the second PCR which was carried out in a 100 
/11 volume using 100 pmol of $2 and R4. The amplification products 
of the second PCR were subcloned into pGEM1. The amino acid 
sequence of mouse Rab5b was found to be 100% identical to human 
Rab5b [22]. 
2.2. Cloning of canine Rab5c 
A lambda UNI-ZAP XR (Stratagene) MDCK II cell cDNA library 
[18] was probed with a PCR fragment spanning the mouse Rab5c 
sequence between the first and second conserved GTP-binding site 
motifs [21]. Out of the 300,000 plaques probed, four turned out positive. 
After plaque purification and in vivo excision according to the manu- 
facturer's procedure (Stratagene), the cDNA inserts in pBluescript 
SK(-) were sequenced using the Pharmacia T7 polymerase kit and the 
supplier's protocol for double-stranded DNA templates. Two of the 
positive clones showed Rab5c sequence, one being apparently full- 
length. The complete sequence of this insert was determined by the 
'primer walking' strategy. Duplicate lifts were performed using nitrocel- 
lulase sheets (Schleicher and Schuell). The probe fragment was labelled 
with [~-3-~P]dCTP by random hexanucleotide priming as described [24]. 
The filters were hybridized overnight at 42°C in 50% formamide 
5 x Denhardt's solution, 5 SSC, 1% SDS. 
2.3. RNA Preparation and Northern blot analysis 
RNA preparation and Northern blot hybridization were performed 
as described [25]. The primer pairs used for the preparation of the 
radiolabelled PCR probes were 5'-AGCTGAATTCAGGAAACAA- 
GGCTG-3'/5'-CTGAGGATCCTTACTGACTCCTGGTTGGCTG- 
CG3' (Rab5a) and 5'-CAGCTTTGATCCCTGCCAAGGC-3'/Sp6 
(Rab5b). In the case of Rab5a, the filters were washed at low stringency 
(2 x SSC. 0.5% SDS, 60°C). 
2.4. Antibodies 
Polyclonal rabbit antisera directed against Rab5a, Rab5b or Rab5c 
were raised using synthetic peptides (PKNEPQNPGANSARGR, 
KQNLGGAAGRSRGVDLHEQS and KQNAAGAPSRNRGVDL- 
QENS, respectively) corresponding to the C-terminal hypervariable 
region. The peptides were coupled to keyhole limpet hemocyanin and 
purified as previously described [18]. The mouse hybridoma cell line 
9E 10 producing amonoclonal ntibody against the c-myc epitope [26] 
was a gift from Dr. Stephen Fuller. The antibody was produced and 
purified as described [27]. The monoclonal ntibody against the human 
transferrin receptor was obtained from Boehringer Mannheim (Ger- 
many). 
2.5. Plasmid construction 
All the cDNAs were cloned with appropriate sites into the pGEM1 
vector under the T7 promoter so that they could be used in the vT7 
recombinant vaccinia virus expression system. Rab5b and Rab5c 
cDNAs were also cloned in the pGEM-myc plasmid [28] that carries 
13 amino acids containing the myc epitope recognized by the 9El0 
monoclonal ntibodies [26]. The Rab5a Ile ~-~3 mutant was constructed 
as preciously described [20]. The Rab5b Leu 79, Rab5b Ile 133, Rab5c 
Leu 8°, Rab5c Ile TM mutants were made by the PCR mediated mutagene- 
sis [29] using in the first amplification the mutated oligonucleotides 
5'-GTGGTATCGCTCCAGCCCAGCAGTGTC- 3', 5'-CAGCTTTG- 
ATCCCTGCCAAGGC-3', 5'-GTGATACCGCTCCAGTCCAGCT- 
GTGT-3' and 5'-CGTCATTGCACTCGCGGGGATCAAGGCAG- 
ACCTGGCCAGCA-3', respectively. We used as outer primers 
oligonucleotides corresponding to the SP6 and T7 promoters present 
in the vector. The resulting mutated bands were isolated by agarose gel 
electrophoresis, purified and cloned into pGEM1 under the control of 
the T7 promoter. The bands were then sequenced completely to ensure 
that the wanted mutations were present and that no'additional ones 
were introduced by the Taq polymerase. 
2.6. Cell culture and transfection 
BHK cells were grown at 37°C in GMEM supplemented with 10% 
tryptose phosphate broth, 5% foetal calf serum, 2 mM glutamine, 100 
U/ml penicillin and 10 ]lg/ml streptomycin i  a 5% CO2 incubator. 
The cells were split on 24-well plates the day before the experiment 
so that they could be 80% confluent before transfection. Infection by 
the vT7 recombinant vaccinia virus and subsequent lipofection using 
DOTAP (Boehringer Mannheim) were performed as previously de- 
scribed [19]. Briefly the cells were infected with 5-10 pfu/cell of vaceinia 
recombinant T7 virus for 30 min at room temperature with intermittent 
shaking in GMEM and subsequently transfected with 2.0 ,ug of the 
appropriate plasmid using DOTAP following the manufacturer instruc- 
tions. The transfection was always performed inthe presence of 10 mM 
hydroxyurea, blocking DNA replication to prevent the virus to enter 
in the late phase. Four to five hours after transfection the cells were 
processed either for immunofluorescence or for internalization assays. 
In the case of transfection with hTR we further incubated the cells for 
90 min at 37°C with cycloheximide (10/lg/ml). The transfection was 
prolonged to 7 h when the cells were needed for the preparation of 
cytosol used in the fusion assay. 
2. 7. Con[ocal immunofluorescence microscopy 
Immunofluorescence was performed essentially as described [30]. 
Before fixation with 3% paraformaldehyde cells on 10 mm diameter 
round coverslip were permeabilized with 0.1% saponin in 80 mM PIPES 
(pH 6.8), 5 mM EGTA and 1 mM MgCI z for 3'. After fixation the cells 
were washed with PBS and then a solution of 50 mM NH4CI in PBS 
was applied to quench. The first antibodies when used on overexpressed 
cells were diluted so that the endogenous protein was not detectable. 
Secondary antibodies, FITC- and TRITC-labelled onkey anti-mouse 
and anti-rabbit affinity purified were obtained from DiaNova (Ger- 
many). In the case of double immunofluorescence th  two different 
antibodies were added simultaneously to the cells. The coverslips were 
viewed with the EMBL confocal microscope and the optical section 
examined were 0.4/Ira thick. 
2,8. In vitro fusion of early endosomes 
The assay was performed essentially as described [20,31]. Briefly 
BHK cells were allowed to internalize avidin or biotinylated horse- 
radish peroxidase (bHRP). After internalization cells were washed ex- 
tensively and homogenized; subsequently early endosomal fractions 
were prepared using a flotation gradient [20]. The two populations of 
early endosomes were mixed in the presence of ATE rat liver cytosol 
at a concentration of 4 mg/ml, and cytosol from BHK cells overex- 
pressing Rab5a, Rab5b, Rab5c, Rab5a Ile j33, Rab5b Ile u~ or Rab5c 
lle TM. After 45 min at 37°C the avidin-bHRP complexes were im- 
munoprecipitated with an anti-avidin antibody in the presence of deter- 
gents and the amount of fusion quantified measuring the HRP enzy- 
matic activity using a-dianisidine as previously described [32]. 
2.9. Estimation of transferr& endocytosis 
Human transferrin was labelled to a specific activity of 107 cpm/mg 
using Iodogen [33]. Internalization of ~25I-transferrin was performed 
essentially as previously described [27]. After 4 h of transfection cells 
were washed with cold PBS containing 0.1% BSA and were allowed to 
bind ~25I-transferrin for 90 min on ice. The cells were then washed 
extensively on ice with PBS/BSA and then incubated for different times 
at 37°C. After the incubation the medium was collected. Cells were then 
treated with 3 mg/ml of pronase (Sigma) for 30 min on ice and subse- 
quently collected and spun at 2,500 rpm. The medium preciously col- 
lected, the supernatant and the cells represented the amount of transfer- 
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rin recycled, membrane-bound and internalized, respectively. The 
measurements of ~25I-transferrin were performed using an NE 1612-Z- 
counter (Nuclear Enterprises). 
3. Results 
3.1. Molecular cloning of Rab5b and Rab5c cDNAs 
We previously described the isolation of partial clones for 
Rab5b and Rab5c from mouse kidney using a PCR-based clon- 
ing approach [21]. Using a combination of cDNA library 
screening and RACE protocols we have obtained cDNAs en- 
coding the full-length proteins and determined their nucleotide 
sequence. Fig. 1A shows the alignment of the deduced amino 
acid sequences ofcanine Rab5a and Rab5c, and murine Rab5b. 
Rab5b and Rab5c are 88% and 91% identical to the Rab5a 
protein, respectively. The highest sequence identity is in the 
central region spanning the four conserved elements forming 
the GTP-binding site, whereas the highest sequence divergence 
is displayed by the extreme N- and C-terminal domains. In view 
of the established role of the C-terminus in targeting Rab pro- 
teins to their membranes [34,35], it is noteworthy that a 
RxRGVDLxE sequence and the Cysteine-motif (-CCSN) re- 
sponsible for the geranylgeranylation of Rab5a [36] are shared 
by the three isoforms. 
We next examined the pattern of expression of Rab5a and 
Rab5b in comparison with that of Rab5c [25] by Northern blot 
hybridization on adult mouse tissues. Transcripts of 2.8 kb, 3.6 
kb and 1.8 kb were detected using the Rab5a, Rab5b (Fig. IB) 
and Rab5c probes (not shown), respectively. The three messen- 
ger RNAs were found to be ubiquitously expressed. Only in the 
intestine the level of Rab5b mRNA appeared to be considera- 
bly lower than that from the other tissues examined. 
These data indicate that mammalian cells express at least 
three isoforms of Rab5 which share high amino acid sequence 
identity and display a similar tissue xpression and distribution. 
Previous tudies have demonstrated that distinct structural do- 
mains pecify the membrane localization and activity of RAb5a 
[34,37] and other Rab proteins [35,38]. The C-terminal domain 
functions in targeting the protein to the early endosomes but 
it is not sufficient o confer Rab5a function [34,37]. The N- 
terminus and the regions predicted to undergo nucleotide- 
dependent conformational changes (the effector domain or 
switchl, ~2/L5 or switch2 and ct3/L7) are additionally required 
for the regulatory role of Rab5a in endocytic transport [31,37]. 
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Fig. 1. Amino acid sequence and mRNA expression ofRab5a, Rab5b and Rab5c. (A) Amino acid sequence omparison between canine Rab5a, 
murine Rab5b and canine Rab5c. All conserved residues are boxed. The effector loop2, c~2/L5 and 0~3/L7 regions are shaded. The nucleotide s quences 
of Rab5b and Rab5c are available from the EMBL/GenBank/DDB under the Accession Numbers X84239 and Z27110, respectively. (B) Northern 
blot analysis of Rab5a and Rab5b on adult mouse tissues. The mRNA for Rab5a and Rab5b are 2.8 kb and 3.6 kb long, respectively. The amount 
of RNA loaded on each lane was checked by hybridization with a GAPDH probe. 
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Fig. 2. Localization of Rab5a, Rab5b and Rab5c by double immunofluorescence microscopy. BHK cells grown on coverslip were infected with the 
vT7 vaccinia recombinant virus and either transfected with the human transferrin receptor (hTR) or with Rab5 constructs. Double immunofluores- 
cence and confocal immunofluorescence analysis was performed as described insection 2. All these images are one optical section of 0.4/.tm. Bar 
10/~m. (A-H) Infected and transfected cells expressing hTR were stained using anti-hTR antibody (A,C,E,G) and affinity purified anti-Rab5b (B,D) 
or anti-Rab5c antibodies (F,H). (I-L) BHK cells transfected with myc-Rab5b (I,J) or myc-Rab5c (K,L) plasmids were stained with 9El0 monoclonal 
anti-myc antibody (I,K) and with affinity purified anti-Rab5a polyclonal ntiserum (J,L). (M-P) BHK cells were transfected with Rab5b Leu 79 (M,N) 
or Rab5c Leu 8° (O,P) plasmids and stained with affinity purified anti-Rab5b or anti-Rab5c antibodies, respectively. 
Given the high sequence conservation i these structural ele- 
ments, the three Rab5 isoforms can be predicted to share the 
same localization and functional role. We therefore tested this 
hypothesis experimentally b determining the intracellular lo- 
calization and functional role of Rab5b and Rab5c in Baby 
Hamster Kidney (BHK) cells. 
3.2. Localization o f  Rab5b and Rab5c 
To determine the intracellular localization of Rab5b and 
Rab5c proteins, polyclonal rabbit antisera were raised against 
peptides corresponding to the C-terminal region, as this dis- 
plays the lowest sequence conservation among the three 
isoforms. The antibodies were affinity-purified asdescribed in 
section 2 and tested against the various isoforms by im- 
munoblotting and immunofluorescence staining on BHK cells 
overexpressing either Rab5a, or Rab5b or Rab5c using the T7 
RNA polymerase-recombinant v ccinia virus system [19,39]. 
The antibodies resulted to be specific for either isoform. As for 
anti-Rab5a ntibodies [18], anti-Rab5b and -Rab5c antibody 
recognized a single band by Western blot analysis. Both the 
intensity of the immunoblot signal and that of the immunofluo- 
rescence labelling were enhanced upon overexpression f the 
protein against which the antibody was raised but not of the 
other isoforms (data not shown). The affinity purified antibod- 
ies were therefore used to investigate he intracellular localiza- 
tion of the individual Rab5 isoforms. The Rab5a protein has 
been previously localized to the plasma membrane, clathrin 
coated vesicles and early endosomes and its immunofluores- 
cence staining pattern overlaps with that of transferrin receptor 
(TR) [18,19]. We first examined the localization of Rab5b and 
Rab5c proteins in BHK cells expressing the human hTR) using 
the vaccinia virus-based system by double immunofluorescence 
confocal microscopy. Most of the endocytic structures labeled 
by the anti-hTR monoclonal ntibody were also stained posi- 
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Fig. 3. Cytosols containing overexpressed Rab5b or Rab5c are able to 
stimulate arly endosome fusion in vitro. Cytosol was prepared from 
BHK cells infected with vT7 and transfected with plasmids encoding 
Rab5a, Rab5b, Rab5c, Rab5a Ile ~33, Rab5b Ile 133 or Rab5c Ile ~34 for 
7 h. (A) Western blot analysis on cytosol prepared from transfected cells 
was performed using affinity purified anti-Rab5a, nti-Rab5b and anti- 
Rab5c antisera. The additional band present in lane 1-3 and indicated 
with an asterisk is due to cross-reactivity of the anti-Rab5a ntisera 
with a vaccinia virus protein. The Rab5b Ile 133 protein migrates lower 
compared to w.t. (B) GTP overlay on the different cytosol containing 
overexpressed Rab5s w.t. and mutant proteins. (C) Cytosol overex- 
pressing the different Rab5 proteins and their corresponding mutant 
was used in the in vitro fusion assay between early endosomes. The 
effect on fusion is expressed as percentage ofstimulation or inhibition 
of the fusion activity obtained with cytosol from control BHK cells 
infected with the vT7 vaccinia recombinant virus. 
tive with both the anti-Rab5b and anti-Rab5c affinity purified 
antibodies (Fig. 2A-H). To directly compare the localization of 
the Rab5 isoforms, we tagged the Rab5b and Rab5c proteins 
at their N-termini with the c-myc epitope and we transiently 
expressed them in BHK cells using the vaccinia T7 RNA 
polymerase system. The staining pattern of the anti-c-myc mon- 
oclonal antibody 9El0 was then compared with that of the 
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affinity-purified anti-Rab5a polyclonal antibody. Extensive 
colocalization between myc-Rab5b and Rab5a (Fig. 2I-J), and 
between myc-Rab5c and Rab5a (Fig. 2K-L) was observed. 
These morphological results indicate that the three Rab5 
isoforms colocalize within hTR-positive endocytic ompart- 
ments. 
3.3. Morphological alterations of the earl), endosomes upon 
overexpression f w.t. and mutant Rab5 isoforms 
Rab5a is a rate-limiting regulatory GTPase for the early 
endocytic pathway in mammalian cells. Overexpression f wild- 
type Rab5a results in the appearance of enlarged early en- 
dosomes [19]. Larger vesicles than normal were also observed 
in cells overexpressing the Rab5b and Rab5c proteins (Fig. 
2I-L) compared to control cells (Fig. 2A-H), suggesting that, 
similar to Rab5a, the two Rab5 isoforms regulate the dynamics 
of the early endosome compartment. We wanted to confirm this 
point by investigating whether the expression of dominant in- 
terfering mutants causes alterations in the morphology ofendo- 
cytic organelles, as previously shown for Rab5a. Expression of 
the GTPase-deficient mutant Rab5a Leu 79 has a more promi- 
nent effect than wild type Rab5a in expanding the size of the 
early endosomes [27]. In contrast, expression of the Rab5a Ile ~33 
and Rab5a Asn 34 mutants leads to the accumulation of very 
small endocytic structure at the periphery of the cell [19,27]. We 
therefore introduced similar mutations in the Rab5b and Rab5c 
proteins, transiently expressed these molecules in BHK cells 
using the vaccinia expression system and analysed the endo- 
cytic profiles in the transfected cells by immunofluorescence 
confocal microscopy using the affinity purified anti-Rab5b and 
anti-Rab5c antibodies. Expression of the Rab5b Ile 133 and 
Rab5c Ile 134 mutants caused the appearance of smaller endo- 
cytic vesicles than those present in control cells (not shown). In 
contrast, cells expressing the Rab5b Leu 79 (Fig. 2M,N) and 
Rab5c Leu s° (Fig. 20,P) mutants displayed very large endocytic 
structures imilar to those obtained upon expression of the 
Rab5a Leu 79 mutant protein [27]. Thus, expression of wild type 
and mutant Rab5a, Rab5b and Rab5c proteins induce similar 
morphological terations of the early endosome compartment. 
3.4. Rab5b and Rab5c regulate the fusion of early endosomes in
vitro 
Rab5a controls the homotypic fusion between early en- 
dosomes in vitro [20]. To further characterize the functional 
properties of Rab5b and Rab5c, we prepared cytosols from 
BHK cells overexpressing the Rab5a, Rab5b, Rab5c, Rab5a 
Ile 133, Rab5b Ile ~33 or Rab5c Ile ~34 proteins and tested them in 
the fusion assay. Western blot analysis using affinity-purified 
anti-Rab5a, -Rab5b, and -Rab5c antibodies confirmed that the 
various proteins were expressed at comparable levels in the 
cytosol from transfected BHK cells (Fig. 3A). As expected from 
previous tudies [19], binding of [~32p]GTP by ligand blotting 
was detected for the wild type but not for the mutant proteins 
(Fig. 3B). Fig. 3C shows the results of the fusion assay. While 
cytosols containing the overexpressed wild type Rab5a, Rab5b 
and Rab5c stimulated the early endosomes fusion by up to 
100%, the mutant proteins decreased the efficiency of fusion. 
Rab5a appeared to exert he highest stimulatory effect whereas 
Rab5c Ile ~34 was the strongest inhibitor. These differences how- 
ever, may reflect small variations in the concentration of cy- 
tosolic isoprenylated proteins. 
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Fig. 4. Rab5b and Rab5c regulate, like Rab5a, the kinetics of transfer- 
rin endocytosis n vivo. BHK cells were transfected for 4 h with the 
human transferrin receptor (hTR) plasmid alone (closed triangle) or 
together with one of the following plasmids: Rab5a (closed square), 
Rab5b (open circle), Rab5c (open square). The cells were then allowed 
to bind t25I-hTf or 2 h at 0°C. After binding the cells were washed 
extensively and incubated at 37°C for different periods of time to allow 
internalization. Internal transferrin was calculated as the percentage of
total transferrin bound that became pronase resistent after internaliza- 
tion. Separate plots of the first 6 min of internalization (A) and of the 
entire experiment (B) are shown to visualize better the kinetics of 
internalization and recycling of ~251-hTf. Each time point represents he 
mean of triplicate samples and the bar is the stand ard error of the mean 
when larger then the size of the symbol. 
3.5. Rab5b and Rab5c regulate endocytosis in vivo 
We next examined whether the Rab5b and Rab5c proteins 
also had the ability to increase the kinetics of endocytosis n 
vivo. For these experiments we transiently expressed in BHK 
cells hTR alone or in combination with one of the three wild 
type or mutant proteins. Consistent with previous data [19], 
overexpression f Rab5a increased the rate of transferrin endo- 
cytosis, and this effect was shared by wild type Rab5b and 
Rab5c (Fig. 4A). In contrast, expression of the Rab5a lie ~33, 
Rab5b Ile ~33 and Rab5c lie TM mutant proteins caused a ~40% 
inhibition in the rate of transferrin internalization (data not 
shown). Recycling to the cell surface (Fig. 4B) was slightly 
accelerated by the wild type proteins. 
In conclusion, these data demonstrate hat the three Rab5 
isoforms share a regulatory function on transport in the early 
endocytic pathway. 
4. Discussion 
We have cloned the cDNAs encoding full-length Rab5b and 
Rab5c proteins. Together with Rab5a they form a subgroup of 
closely related isoforms. Similar subgroups exist also for other 
Rab proteins. Given that the Rab3 subgroup seems to be heter- 
ogeneous, its members displaying cell-type specific expression 
and function, it became important o investigate the function 
of the Rab5 subgroup. To rigorously address the role of the 
three Rab5 proteins in mammalian cells we used a combination 
of approaches. We showed that the mRNAs for the three genes 
are expressed in all organs examined and that, by confocal 
immunofluorescence microscopy, the three isoforms colocalize 
at the level of plasma membrane and early endosomes. Moreo- 
ver, Rab5b and Rab5c stimulated early endosome fusion in 
vitro and transferrin endocytosis n vivo. Thus, the ability of 
Rab5a to regulate transport in the early endocytic pathway is 
also shared by the Rab5b and Rab5c isoforms. Since Rab5b 
and Rab5c proteins appear to be ubiquitously expressed, like 
Rab5a, we conclude that three Rab5 proteins regulate ndocy- 
tosis in eukaryotic ells. 
The Rab5a, Rab5b and Rab5c proteins colocalize to a TR- 
positive ndosomal compartment. One implication of our study 
is that these three GTPases must share a common determinant 
for targeting to the early endosomes. Previous experiments 
have shown that the targeting signal for Rab proteins is present 
in the C-terminal hypervariable domain [34]. The C-terminus 
of Rab7 is sufficient o target Rab5a to the late endosomes [34] 
and the C-terminus of Rab5a can target Rab6 to the plasma 
membrane and early endosomes [37]. Similarly, the hypervaria- 
ble C-terminal domains of Yptlp and Sec4p in yeast were 
shown to be responsible for the targeting of the two proteins 
[35]. Comparison of the primary sequence of the three Rab5 
isoforms revealed a conserved RxRGVDLxE motif that may 
be important for the interaction with the specific membrane 
targeting machinery. 
The C-terminal hypervariable domain is required for organ- 
elle targeting but is not sufficient o confer functional specific- 
ity. The N-terminus and the regions involved in the conforma- 
tional change occurring upon GTP-hydrolysis, ~2/L5 and ~3/ 
L7 as well as the effector loop, have been found to be specific 
structural determinants for the activity of Rab proteins 
[35,37,38]. When these regions were transplanted on Rab6 they 
transmitted Rab5a function to the chimeric protein [37]. Inter- 
estingly, while the N-terminal domain is more divergent, the 
three Rab5 proteins are highly conserved in the 0~2/L5, ~3/L7 
regions and effector domain. This suggests that the three pro- 
teins are likely to have common regulatory factors. Three 
Rab5-1ike proteins, named Ypt51p, Ypt52p and Ypt53p, with 
a conserved ~2/L5 region have been identified in yeast and 
found to have slightly different but overlapping functions in the 
endocytic pathway [23]. The strong conservation between the 
isoforms and the presence of subgroups throughout evolution 
suggest an important role of the three proteins in the regulation 
of endocytic trafficking. 
The presence of three Rab5 isoforms may reflect an evolu- 
tionary need to ensure Rab5 function even in the presence of 
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harmful mutation. Alternatively, each isoform could fulfill a 
distinct role and be responsible for a fine regulation of the early 
endocytic pathway. However, the differences between them 
could be too subtle to be detected even with the spectrum of 
techniques we employed. For example, although the three Rab5 
proteins are localized to the same compartment asdetermined 
by confocal immunofluorescence microscopy, they could still 
be restricted to specific microdomains of the early endosomes. 
Electron microscopy studies will be required to address this 
question, provided that antibodies with high sensitivity of de- 
tection become available. Rab5 isoforms may also have differ- 
ent localization and function in polarized cells. Rab5a is associ- 
ated with, and regulates endocytosis from, both the apical and 
the basolateral domain in epithelial cells [40]. Similarly, in neu- 
rons Rab5a has a role in both axonal and dendritic endocytosis 
[41]. It is not known whether Rab5b and Rab5c are restricted 
to either endocytic domain. 
It will also be important to establish whether the activity of 
the three Rab5 proteins is differentially regulated. In the case 
of the Rab4 subgroup, Rab4a and Rab4b may have a similar 
role in endocytosis [17] (Bucci and Zerial, unpublished ata). 
However, whereas Rab4a is phosphorylated in the C-terminal 
domain by the cdc2 kinase during mitosis and upon phospho- 
rylation becomes cytosolic [42], Rab4b does not contain this 
phosphorylation site. Among the three Rab5 isoforms, only 
Rab5c contains a putative phosphorylation site for cdc2 kinase 
(S 196) in its C-terminus. It remains to be demonstrated whether 
this site is indeed phosphorylated during mitosis and whether 
this post-translational modification plays a role in selectively 
regulating membrane association of Rab5c. 
Acknowledgements." We wish to thank Angelika Giner for excellent 
technical assistance and Dr. H. Stenmark for critical reading of the 
manuscript. This work was supported by grants from the Human Fron- 
tier Science Program Organization (RG-380/92) and the European Ec- 
onomic Community (BIO2-CT93-0205) (M.Z.), and by Progetto Final- 
izzato Ingegneria Genetica of the Italian Consiglio Nazionale delle 
Ricerche (C.B.B.). 
References 
[1] Valencia, A., Chardin, R, Wittinghofer, A. and Sander, C. (1991) 
Biochem. 30, 4637~,648. 
[2] Kahn, R.A., Kern, F.G., Clark, J., Gelmann, E.P. and Rulka, C. 
(1991) J, Biol. Chem. 266, 2606-2614. 
[3] Tsuchiya, M., Price, S.R., Tsai, S.-C., Moss, J. and Vaughan, M. 
(1991) J. Biol. Chem. 266, 2772-2777. 
[4] Kuge, O., Dascher, C., Orci, L., Rowe, T., Amherdt, M., Plutner, 
H., Ravazzola, M., Tanigawa, G., Rothman, J.E. and Balch, W.E. 
(1994) J. Cell Biol. 125, 51-65. 
[5] Tisdale, E.J., Bourne, J.R., Khosravi-Far, R., Der, C.J. and Balch, 
W.E. (1992) J. Cell Biol. 119, 74%761. 
[6] Jena, B.P., Gumkowski, F.D., Konieczko, E.M., Fischer von 
Mollard, G., Jahn, R. and Jamieson, J.D. (1994) J. Cell Biol. 124, 
43 53. 
[7] Darchen, F., Zahraoui, A., Hammel, F., Monteils, M.P., Tavitian, 
A. and Scherman, D. (1990) Proc. Natl. Acad. Sci. USA 87, 5692 
5696. 
[8] Johannes, L., Lledo, P.-M., Roa, M., Vincent, J.-D., Henry, J.-P. 
and Darchen, F. (1994) EMBO J. 13, 2029-2037. 
[9] Fischer von Mollard, G., Mignery, G.A., Baumert, M., Perin, 
M.S., Hanson, T.J., Burger, P., Jahn, R. and Siidhof, T.C. (1990) 
Proc. Natl. Acad. Sci. USA 87, 1988-1992. 
[10] Fischer von Mollard, G., Stidhof, T.C. and Jahn, R. (1991) Nature 
349, 79 81. 
[ll] Fischer von Mollard, G., Stahl, B., Khokblatchev, A., Siidhof, 
T.C. and Jahn, R. (1994) J. Biol. Chem. 269, 10971-10974. 
[12] Weber, E., Berta, G., Tousson, A., St. John, P., Green, M.W, 
Gopalokrishnan, U., Jilling, T., Sorsher, E.J., Elton, T.S., 
Abrahamson, D.R. and Kirk, K.L. (1994) J. Cell Biol. 125, 583- 
594. 
[13] Lledo, E-M., Vernier, R, Vincent, J.-D., Mason, W.T. and Zorec, 
R. (1993) Nature 364, 540-544. 
[14] Baldini, G., Hohl, T., Lin, H.Y. and Lodish, H.F. (1992) Proc. 
Natl. Acad. Sci. USA 89, 5049-5052. 
[15] Chavrier, P., Vingron, M., Sander, C., Simons, K. and Zerial, M. 
(1990) Mol. Cell. Biol. 10, 6578~585. 
[16] van der Sluijs, P., Hull, M., Zahraouri, A., Tavitian, A., Goud, B. 
and Mellman, I. (1991) Proc. Natl. Acad. Sci. USA 88, 6313-6317. 
[17] van der Sluijs, R, Hull, M., Webster, R, Mille, P., Goud, B. and 
Mellman, I. (1992) Cell 70, 729-740. 
[18] Chavrier, P., Parton, R.G., Hauri, H.R, Simons, K. and Zerial, 
M. (1990) Cell 62, 317-329. 
[19] Bucci, C., Parton, R.G., Mather, I.H., Stunnenberg, H., Simons, 
K., Hoflack, B. and Zerial, M. (1992) Cell 70, 715 728. 
[20] Gorvel, J.-R, Chavrier, P., Zerial, M. and Gruenberg, J. (1991) 
Cell 64, 915-925. 
[21] Chavrier, R, Simons, K. and Zerial, M. (1992) Gene 112,261-264. 
[22] Wilson, D.B. and Wilson, M.R (1992) J. Clin. Invest. 89, 996- 
1005. 
[23] Singer-Krfiger, B., Stenmark, H., Dtisterh6ft, A., Philippsen, R, 
Yoo, J.-S., Gallwitz, D. and Zerial, M. (1994) J. Cell Biol. 125, 
283-298. 
[24] Feinberg, A.R and Vogelstein, B. (1983) Anal. Biochem. 132, 
6-13. 
[25] Liitcke, A., Jansson, S., Parton, R.G., Chavrier, R, Valencia, A., 
Huber, L., Lehtonen, E. and Zerial, M. (1993) J. Cell Biol. 121, 
553-564. 
[26] Evan, G.I., Lewis, G.K., Ramsay, G. and Bishop, J.M. (1985) 
Mol. Cell. Biol. 5, 3610-3616. 
[27] Stenmark, H., Parton, R.G., Steele-Mortimer, O., Ltitcke, A., 
Gruenberg, J. and Zerial, M. (1994) EMBO J. 13. 1287-1296. 
[28] Olkkonen, V.M., Dupree, R, Killisch, I., Ltitcke, A., Zerial, M. 
and Simons, K. (1993) J. Cell Sci. 106, 1249-1261. 
[29] Landt, O., Grunert, H.-R and Hahn, U. (1990) Gene 96, 125 128. 
[30] Zerial, M., Parton, R., Chavrier, R and Frank, R. (1992) Methods 
Enzymol. 219, 398M07. 
[31] Steele-Mortimer, O., Clague, M.J., Huber, L.A., Chavrier, R, 
Gruenberg, J. and Gorvel, J.-R (1994) EMBO J. 13, 34-41. 
[32] Marsh, M., Schmid, S., Kern, H., Harms, E., Male, R, Mellman, 
I. and Helenius, A. (1987) J. Cell Biol. 104, 875 886. 
[33] Fraker, RJ. and Speck, J.C. (1978) Biochem. Biophys. Res. 
Comm. 80, 849-857. 
[34] Chavrier, R, Gorvel, J.-R, Steltzer, E., Simons, K., Gruenberg, J. 
and Zerial, M. (1991) Nature 353, 769-772. 
[35] Brennwald, E and Novick, R (1993) Nature 362, 560-563. 
[36] Magee, T. and Newman, C. (1992) Trends Cell Biol. 2, 318 323. 
[37] Stenmark, H., Valencia, A., Martinez, O., Ullrich, O., Goud, B. 
and Zerial, M. (1994) EMBO J. 13, 575 583. 
[38] Dunn, B., Stearns, T. and Botstein, D. (1993) Nature 362, 563 
565. 
[39] Fuerst, T.R., Niles, E.G., Studier, F.W. and Moss, B. (1986) Proc. 
Natl. Acad. Sci. USA 83, 8122-8126. 
[40] Bucci, C., Wandinger-Ness, A. Lfitcke, A., Chiariello, M., Bruni, 
C.B. and Zerial, M. (1994) Proc. Natl. Acad. Sci. USA 91, 5061- 
5065. 
[41] de Hoop, M.J., Huber, L.A., Stenmark, H., Williamson, E., Zerial, 
M., Parton, R.G. and Dotti, C.G. (1994) Neuron 13, 11-22. 
[42] van der Sluijs, R, Hull, M., Huber, L.A., Mille, R, Goud, B. and 
Mellman, I. (1992) EMBO J. 11, 4379-4389. 
